What's happening
This bill allows pharmacists to administer only FDA-approved medications by injection for mental health and substance use disorders.
Why it matters
Expands access to mental health and substance use disorder treatments. by allowing pharmacists—not just doctors or nurses—to administer certain injectable medications, potentially making it easier for patients to receive timely care, especially in communities with fewer healthcare providers.
Limits pharmacist-administered injections to only FDA-approved medications. for these conditions, ensuring that only treatments with established safety and efficacy are allowed, which may reassure patients and providers about the quality of care.
Imposes strict requirements for pharmacist training, patient consent, and privacy. , establishing standards for competency, emergency preparedness, and communication with prescribers, which could help maintain patient safety and trust as pharmacists take on these expanded roles.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Pharmacists administering mental health and substance use disorder medications
The bill would explicitly limit authorized deltoid injections to FDA-approved medications and require regulations ensuring that restriction.
Patients receiving mental health or substance use disorder treatment
The bill would require FDA-approved medications for these pharmacy injections, while retaining requirements for consent, privacy and prescriber approval for maintenance treatment.
Licensed prescribers
The bill would specify that prescriptions or orders authorizing pharmacists to administer these injections must cover FDA-approved medications, while retaining notification and reporting requirements.
State Education Department and Department of Health
The bill would place rulemaking with the education commissioner in consultation with the Department of Health and other agencies as necessary, rather than jointly with the Department of Health.
Headline styles
Let Pharmacists Give FDA Meds
Plain English, a few words. Used as the page title.
Sponsors
Assembly Member · Assembly District 108
1 Co-sponsor
History
- Signed chap.5
- Delivered to governor
- Returned to assembly
- Passed senateVote 55–4
- 3rd reading cal.62
- Substituted for S853
- Referred to rules
- Delivered to senate
- Passed assembly
- Ordered to third reading rules cal.56
- Rules report cal.56
- Reported
Show 2 earlier actions
- Reported referred to rules
- Referred to higher education
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Let Pharmacists Give FDA Meds
Senate Floor Calendar · Sponsor Neil D. Breslin
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
608
2023-2024 Regular Sessions
IN ASSEMBLY
January 10, 2023
Introduced by M. of A. McDONALD -- read once and referred to the Committee on Higher Education
AN ACT to amend the education law, in relation to medications approved by the U.S. Food and Drug Administration and administered by pharmacists
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Paragraph b of subdivision 22 of section 6802 of the education law, as added by a chapter of the laws of 2022 amending the education law relating to the definition of the practice of pharmacy, as proposed in legislative bills numbers S. 4870-B and A. 3040-B, is amended to read as follows:
b. The injection of medications into the deltoid muscle for the treatment of mental health and substance use disorder, as prescribed or ordered by a licensed prescriber, acting within the scope of their practice in this state and in accordance with regulations promulgated by the commissioner [and], in consultation with the department of health [in consultation with] and any other state agencies as necessary, [but not be limited to, providing] provided that:
(1) Such administration is conducted pursuant to a valid prescription or order that authorizes a pharmacist to administer medications approved by the U.S. Food and Drug Administration for the treatment of mental health and substance use disorder and the pharmacist notifies the licensed prescriber that the administration is complete. Administration in a pharmacy may not commence until after the patient has received the initial injection and is considered eligible for maintenance treatment by the licensed prescriber.
(2) Such prescription may be subject to reassessment at appropriate intervals, as determined by the licensed prescriber.
(3) Such activity is conducted in accordance with regulations, promulgated or adopted by the commissioner [and], in consultation with the
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD04183-01-3
department of health[, in consultation with] and any other state agencies, as necessary, which shall include requirements for the following:
(i) Training accredited by the accreditation council for pharmacy education, that may include educational experiences obtained through pharmacy school curricula, or a similar health authority or professional body appropriate for the medications being administered and their respective patient populations. Such training must be satisfactory to the commissioner and the department of health, in consultation with the board of pharmacy and any other state agencies, as necessary, which shall include, but not be limited to learning modules on techniques for administration by injections, indications, precautions, and contraindications in the use of agent or agents; record keeping and information; and handling emergencies, including anaphylaxis, needle-sticks and cardiopulmonary resuscitation.
(ii) Maintaining continued competency regarding the populations served and medications administered.
(iii) Pre-administration patient consent and education regarding common side effects, drug interactions, injection site reactions and other information routinely provided to patients upon dispensing. If a patient is unable to provide consent, the pharmacist must obtain consent from a person legally responsible when the recipient is incapable of consenting.
(iv) When administering an injection in a pharmacy, the pharmacist shall provide an area for the injection that provides for the patient's privacy.
(v) Record keeping and reporting of such administration by electronic transmission or facsimile to the patient's licensed prescriber, and, to the extent practicable, make himself or herself available to discuss the outcome of such injection, including any adverse reactions, with the licensed prescriber acting within their scope of practice.
(vi) Ensuring that only U.S. Food and Drug Administration approved medications are administered.
§ 2. This act shall take effect on the same date and in the same manner as a chapter of the laws of 2022 amending the education law relating to the definition of the practice of pharmacy, as proposed in legislative bills numbers S. 4870-B and A. 3040-B, takes effect.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.